{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:08:34Z","timestamp":1788869314937,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["R01DK079984"],"award-info":[{"award-number":["R01DK079984"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.nucmedbio.2011.06.007","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T09:21:16Z","timestamp":1317288076000},"page":"65-75","source":"Crossref","is-referenced-by-count":12,"title":["SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies"],"prefix":"10.1016","volume":"39","author":[{"given":"Jonathan S.","family":"Wall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Richey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Oosterhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toin H.","family":"van Kuppevelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.57.121304.131243","article-title":"Amyloidosis","volume":"57","author":"Pepys","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0015","first-page":"691","article-title":"Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits","volume":"66","author":"Baltz","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0020","first-page":"443","article-title":"Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis","volume":"69","author":"Ailles","year":"1993","journal-title":"Lab Invest"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0025","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/39.10.1940305","article-title":"A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis","volume":"39","author":"Snow","year":"1991","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0030","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1474-4422(03)00484-8","article-title":"Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders","volume":"2","author":"van Horssen","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1937-6448(09)76003-4","article-title":"Interactions between heparan sulfate and proteins-design and functional implications","volume":"276","author":"Lindahl","year":"2009","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0040","doi-asserted-by":"crossref","unstructured":"Smits NC, Kurup S, Rops AL, Ten Dam GB, Massuger LF, Hafmans T, et al. The Heparan Sulfate Motif (GlcNS6S-IdoA2S)3, Common in Heparin, Has a Strict Topography and Is Involved in Cell Behavior and Disease. J Biol Chem 285:41143-41151.","DOI":"10.1074\/jbc.M110.153791"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jbiotec.2007.01.022","article-title":"The heparanome\u2013the enigma of encoding and decoding heparan sulfate sulfation","volume":"129","author":"Lamanna","year":"2007","journal-title":"J Biotechnol"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0050","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.2741\/3007","article-title":"The heparanome and regulation of cell function: structures, functions and challenges","volume":"13","author":"Ori","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0076-6879(06)16005-X","article-title":"Phage display-derived human antibodies against specific glycosaminoglycan epitopes","volume":"416","author":"Smits","year":"2006","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0060","doi-asserted-by":"crossref","first-page":"35621","DOI":"10.1074\/jbc.M109.009712","article-title":"Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities","volume":"284","author":"Thompson","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0065","doi-asserted-by":"crossref","first-page":"12960","DOI":"10.1074\/jbc.273.21.12960","article-title":"Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney","volume":"273","author":"van Kuppevelt","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10719-007-9070-z","article-title":"Characterization of anticoagulant heparinoids by immunoprofiling","volume":"25","author":"Wijnhoven","year":"2008","journal-title":"Glycoconj J"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0065-2318(01)57017-1","article-title":"Structure and biological interactions of heparin and heparan sulfate","volume":"57","author":"Casu","year":"2001","journal-title":"Adv Carbohydr Chem Biochem"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0080","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0002-9440(10)65378-3","article-title":"Transgenic mouse model of AA amyloidosis","volume":"154","author":"Solomon","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/13506120500222359","article-title":"Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis","volume":"12","author":"Wall","year":"2005","journal-title":"Amyloid"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0090","first-page":"542","article-title":"Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice","volume":"58","author":"Wall","year":"2008","journal-title":"Comp Med"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0095","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1074\/jbc.M104852200","article-title":"Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies","volume":"277","author":"Dennissen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0100","doi-asserted-by":"crossref","first-page":"19442","DOI":"10.1074\/jbc.M700630200","article-title":"Functions of chondroitin sulfate\/dermatan sulfate chains in brain development. Critical roles of E and iE disaccharide units recognized by a single chain antibody GD3G7","volume":"282","author":"Purushothaman","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0105","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2353\/ajpath.2007.070111","article-title":"Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding","volume":"171","author":"ten Dam","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0110","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bbrc.2004.12.114","article-title":"A diabody that dissociates to monomer forms at low concentration: effects on binding activity and tumor targeting","volume":"327","author":"Huang","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0115","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1073\/pnas.022643999","article-title":"IL-6 transgenic mouse model for extraosseous plasmacytoma","volume":"99","author":"Kovalchuk","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0076-6879(06)12011-X","article-title":"Micro-imaging of amyloid in mice","volume":"412","author":"Wall","year":"2006","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0125","first-page":"665","article-title":"Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis","volume":"56","author":"Snow","year":"1987","journal-title":"Lab Invest"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0130","first-page":"687","article-title":"A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils","volume":"57","author":"Snow","year":"1987","journal-title":"Lab Invest"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/105072501300176372","article-title":"Sodium iodide symporter in health and disease","volume":"11","author":"Shen","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0145","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s002590050272","article-title":"Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis","volume":"25","author":"Hawkins","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0150","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.167.3.903","article-title":"Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component","volume":"167","author":"Hawkins","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0155","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF01254559","article-title":"Imaging amyloidosis with radiolabelled SAP","volume":"22","author":"Hawkins","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0160","doi-asserted-by":"crossref","first-page":"355 e15","DOI":"10.1016\/j.amjmed.2005.08.043","article-title":"Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis","volume":"119","author":"Hazenberg","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0165","first-page":"699","article-title":"Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value","volume":"39","author":"Jager","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0170","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1182\/blood-2010-03-273797","article-title":"Radioimmunodetection of amyloid deposits in patients with AL amyloidosis","volume":"116","author":"Wall","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0175","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1073\/pnas.0502287102","article-title":"In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 2","key":"10.1016\/j.nucmedbio.2011.06.007_bb0180","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/bj3030663","article-title":"Characterization of proteoglycans associated with mouse splenic AA amyloidosis","volume":"303","author":"Stenstad","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0185","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.0300-9475.2004.01516.x","article-title":"Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice","volume":"60","author":"Sugumaran","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0190","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1160\/TH09-02-0091","article-title":"Heparin, heparan sulfate and heparanase in inflammatory reactions","volume":"102","author":"Li","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0195","first-page":"633","article-title":"The role of heparan sulphate in inflammation","volume":"6","author":"Parish","year":"2006","journal-title":"Nat Rev"},{"key":"10.1016\/j.nucmedbio.2011.06.007_bb0200","doi-asserted-by":"crossref","first-page":"26091","DOI":"10.1074\/jbc.272.42.26091","article-title":"Amyloid-specific heparan sulfate from human liver and spleen","volume":"272","author":"Lindahl","year":"1997","journal-title":"J Biol Chem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805111001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805111001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T14:51:00Z","timestamp":1560696660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805111001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0969805111001569"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2011.06.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}